| Announce Date | 04/30/2025 |
| EPS Normalized Actual | $-0.2 (Beat by $0.01) |
| EPS GAAP Actual | $-0.2 (Beat by $0.01) |
| Revenue Actual | $0.070005B |
| Revenue Surprise | Beat by $70.005M |
| Announce Date | 03/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.04 |
| EPS GAAP Estimate | $0.04 |
| Revenue Estimate | $0.095B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1 | 1.81 | 0.94429 | 1.05571 | 0 |
| Dec 2027 | 0.36 | 5.01 | 0.35693 | 0.36307 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.2 | -0.29 | 0.070005B | 92.09% | 37.02M |
| FQ2 2025 (Jun 2025) | -0.28 | -0.28 | 0.067524B | 93.35% | 67.52M |
| FQ1 2025 (Mar 2025) | 0.1 | 0.1 | 0.08274B | 87.87% | 82.74M |
| FQ4 2024 (Dec 2024) | 0.624 | 0.624 | 0.088674B | 76.62% | 88.67M |
| FQ3 2024 (Sep 2024) | -1.03 | -1.03 | 0.005536B | 100% | 5.54M |
| FQ2 2024 (Jun 2024) | -0.0003 | -0.0003 | 0.004492B | 100% | 4.49M |
| FQ1 2024 (Mar 2024) | -0.2 | -0.2 | 0.01004B | 100% | 10.04M |
| FQ4 2023 (Dec 2023) | -0.56 | -0.56 | 0.020729B | 100% | 20.73M |
FQ4 Announce Date
03/28/2026 (Pre-Market)
Consensus EPS Estimates
0.04
Consensus Revenue Estimates
0.095B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.07 | -- | 0.07 | 0.07 | 1 |
| FQ3 2026 (Sep 2026) | 0.07 | 385.71 | 0.07 | 0.07 | 1 |
| FQ2 2026 (Jun 2026) | 0.05 | 660 | 0.05 | 0.05 | 1 |
| FQ1 2026 (Mar 2026) | 0.04 | -150 | 0.04 | 0.04 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ3 2026 (Sep 2026) | 0.12B | 42.62 | 0.12B | 0.12B | 1 |
| FQ2 2026 (Jun 2026) | 0.11B | 38.05 | 0.11B | 0.11B | 1 |
| FQ1 2026 (Mar 2026) | 0.1B | 12.91 | 0.1B | 0.1B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.09 | -0.2 | -0.29 | 145% |
| FQ2 2025 (Jun 2025) | -0.28 | -0.28 | 100% | |
| FQ1 2025 (Mar 2025) | 0.1 | 0.1 | 100% | |
| FQ4 2024 (Dec 2024) | 0.624 | 0.624 | 100% | |
| FQ3 2024 (Sep 2024) | -1.03 | -1.03 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0003 | -0.0003 | 100% | |
| FQ1 2024 (Mar 2024) | -0.2 | -0.2 | 100% | |
| FQ4 2023 (Dec 2023) | -0.56 | -0.56 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.03B | $0.07B | $37.02M | 52.88% |
| FQ2 2025 (Jun 2025) | $0B | $0.07B | $67.52M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.08B | $82.74M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.09B | $88.67M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $5.54M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $4.49M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $10.04M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $20.73M | 100% |